Compare Baroda BNP Paribas Health and Wellness Fund vs ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund
Risk
Very High
Very High
Rating
-
5.0
Min SIP Amount
₹500
₹100
Expense Ratio
2.61
1.99
NAV
₹9.30
₹38.69
Fund Started
09 Jun 2025
25 Jun 2018
Fund Size
₹515.19 Cr
₹6293.14 Cr
Exit Load
Exit Load for units in excess of 10% of the investment,1% will be charged for redemption within 1 year.
Exit load of 1% if redeemed within 15 days.
1 Year
-
4.37%
3 Year
-
25.91%
5 Year
-
15.56%
Equity
95.92%
97.62%
Cash
-0.44%
2.35%
Top 10 Holdings
Sun Pharmaceutical Industries Ltd. | 10.23% |
Lupin Ltd. | 6.29% |
Abbott India Ltd. | 5.53% |
Torrent Pharmaceuticals Ltd. | 5.32% |
Ipca Laboratories Ltd. | 5.28% |
Laurus Labs Ltd. | 4.43% |
JB Chemicals & Pharmaceuticals Ltd. | 4.41% |
Astrazeneca Pharma India Ltd. | 3.92% |
SBI Life Insurance Company Ltd. | 3.45% |
Emcure Pharmaceuticals Ltd. | 3.36% |
Sun Pharmaceutical Industries Ltd. | 12.11% |
Cipla Ltd. | 9.23% |
Mankind Pharma Ltd. | 7.01% |
Biocon Ltd. | 6.08% |
Dr. Reddy's Laboratories Ltd. | 5.97% |
Divi's Laboratories Ltd. | 5.91% |
Lupin Ltd. | 4.09% |
Alkem Laboratories Ltd. | 3.52% |
Syngene International Ltd. | 3.52% |
Aurobindo Pharma Ltd. | 3.30% |
Name
-
-
Start Date
-
-
Description
The scheme is to provide long-term capital appreciation by investing predominantly in equity and equity related instruments of Pharma and Healthcare companies. The Scheme does not guarantee/indicate any returns.
The scheme seeks to generate long-term capital appreciation by creating a portfolio that is invested in equity and equity related securities of pharma, healthcare, hospitals, diagnostics, wellness and allied companies.
Launch Date
09 Jun 2025
25 Jun 2018
